D,L-Lysine Acetylsalicylate — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

8 Recruiting

2 Completed trials

9 Sponsors

6 Countries

Phase III

Phase II/III

Phase IV

Phase III: 4 Phase II/III: 2 Phase III/IV: 1 Phase IV: 4

Indications tested

Chronic coronary syndrome 1 Ischaemic stroke 1 Colorectal cancer metastatic 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Caen Normandie 2 Centre Hospitalier Universitaire Rouen 2 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire De Bordeaux 1 Centre Hospitalier Universitaire De Dijon 1 Centre Hospitalier Universitaire De Nantes 1 Centre Hospitalier Universitaire De Saint Etienne 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 St Antonius Hospital 1

All trials

11 total

Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial Pending

2024-510811-32-00 Phase III 1 country Centre Hospitalier Universitaire De Dijon
Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneou… Recruiting

2023-507545-28-00 Phase IV 1 country Centre Hospitalier Universitaire De Caen Normandie
REPROGRAM-02 : Induction Regorafenib in combination with metronomic cyclophosphamide, capecitabine, and low-dose aspirin followed by chemoth… Recruiting

2024-516709-22-00 Phase II/III 1 country Centre Hospitalier Regional Universitaire
Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentr… Recruiting

2023-508148-23-01 Phase III 1 country Assistance Publique Hopitaux De Marseille
Short versus long antiplatelet therapy after TAVI Recruiting

2023-508208-40-00 Phase II/III 1 country Centre Hospitalier Universitaire De Caen Normandie
AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE Recruiting

2024-515774-27-00 Phase IV 1 country Centre Hospitalier Universitaire De Bordeaux
CARE : Impact of Regorafenib in combination with multimodal metronomic chemotherapy (cyclophosphamide, capecitabine, and low-dose aspirin) o… Recruiting

2023-509761-21-00 Phase III 1 country Centre Hospitalier Regional Universitaire
Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting

2023-504637-42-01 Phase IV 5 countries St Antonius Hospital
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE Recruiting

2022-500974-33-00 Phase III 1 country Centre Hospitalier Universitaire De Saint Etienne
Aspirin in immune thrombocytopenia patients with cardiovascular disease Ended

2024-513846-13-00 Phase III/IV 1 country Centre Hospitalier Universitaire De Toulouse
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended

2023-508454-26-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…

Showing 1–11 of 11 trials

← All drugs A–Z